[Experience in long term use of tamsulosin (Omnik) in patients with chronic prostatitis].
Tamsulosin (omnik), a selective adrenoreceptor blocker-alpha 1A/D, was used in a long-term regimen of chronic prostatitis (CP) treatment conducted in 39 patients. Tamsulosin was given in a standard dose of 0.4 mg once a day for 1 year. The IPSS total scores, quality of life (Qol, Q max) and size of the prostate were assessed. Tamsulosin proved highly effective in symptoms of the lower urinary tracts (SLUT) and CP. In patients with exacerbation of CP and with SLUT combination of tamsulosin with antibacterial, antiinflammatory, immunomodulating and symptomatic therapy raises the treatment efficiency. Tamsulosin monotherapy can be recommended for treatment of micturition disorders in patients with nonaggravated CP.
D'iakov
V V
VV
Govorov
A V
AV
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000077409:Tamsulosin
D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin